Want to see BEAM full AI Analyst Report?
Beam Therapeutics (BEAM) Hedge Fund Trading Activity
Trend: ▼ Hedge Funds Decreased Holdings by 1.1M Shares Last Quarter
Hedge Fund Holdings in BEAM
Based on the 13F filings of 489 Hedge Funds tracked by TipRanks, as submitted to the SEC.
Hedge Fund Confidence Signal
Hedge Fund Activity
Activity
Star Ranking
| Hedge Fund Manager | Star Ranking | Firm | Activity | Holding Change | Value Reported | % of Portfolio | Follow |
|---|---|---|---|---|---|---|---|
 Stanley Druckenmiller | Duquesne Family Office LLC | New | 100.00% | $5,271,552 | 0.10% | ||
 BlackRock, Inc. | Not Ranked | Added | 6.01% | $308,795,641 | 0.05% | ||
| Andrew J.M. Spokes | Farallon Capital Management, L.L.C. | Added | 1.00% | $351,313,111 | 1.62% | ||
 Cathie Wood | ARK Investment Management LLC | Reduced | -15.65% | $351,260,464 | 2.28% |
FAQ
Which hedge funds hold Beam Therapeutics?
The hedge funds that hold the most shares in Beam Therapeutics are Stanley Druckenmiller, BlackRock, Inc. and Cathie Wood.
Are hedge funds buying or selling BEAM?
In the last quarter hedge funds have Decreased their holdings in Beam Therapeutics by 1.1M shares.
Where can I see a list of the best rated hedge funds?
You can see a list of the best hedge funds here.
Who is the best-performing hedge fund manager?
The top-rated hedge fund managers can be seen here: Top Hedge Fund Managers
Does Warren Buffet hold shares in Beam Therapeutics stock?
Warren Buffet currently does not own shares in Beam Therapeutics.
What is a 13F filing, and how does it help investors?
A 13F form, also known as a "Report of Investment Manager," is a quarterly report that investment advisors registered with the Securities and Exchange Commission (SEC) must file if they manage at least $100 million in assets. The 13F form lists all of the publicly traded securities that the investment advisor owns as of the end of the reporting period. To read more about the 13F, click here